Latest C-peptide Stories
ROCKVILLE, Md., May 8, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc.
New research report “Global Peptide Therapeutics Pipeline Insight 2015” elaborated by PNS Pharma is available at MarketPublishers.com. London, UK (PRWEB)
Largest Study to Date of Residual Insulin Production Proves Such Patients Are Not 'Exceptional' BOSTON, Dec.
Transparency Market Research includes new market research report "Peptide Therapeutics Market:Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018" to its
Researchers recently discovered that a tuberculosis vaccine could decrease autoimmunity and boost insulin production in patients who have long-term Type 1 diabetes.
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily restore insulin secretion in human patients with type 1 diabetes.
- A woman chauffeur.
- A woman who operates an automobile.